Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ONC will decline by -2.92% over the next 2 Weeks and hit $262.20 by Friday, June 19, 2026. In that time frame, ONC's share price is expected to range between $251.72 and $272.57.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 19, 2026 | 251.72 | 262.20 | 272.57 |
| Jun 18, 2026 | 251.97 | 262.38 | 273.01 |
| Jun 17, 2026 | 252.12 | 263.25 | 273.47 |
| Jun 16, 2026 | 250.55 | 261.90 | 272.70 |
| Jun 15, 2026 | 248.87 | 259.12 | 269.44 |
| Jun 12, 2026 | 258.17 | 268.57 | 278.84 |
| Jun 11, 2026 | 258.29 | 268.75 | 279.54 |
| Jun 10, 2026 | 259.07 | 269.62 | 279.91 |
| Jun 9, 2026 | 257.78 | 268.27 | 279.14 |
| Jun 8, 2026 | 255.31 | 265.49 | 276.54 |
ONC shares fell -3.51% in Friday, June 5, 2026's trading session, dropping from a previous close of $279.93 to move at $270.10. The stock demonstrated notable intraday movement (see ONC's key stats for a full breakdown), fluctuating between $269.00 and $275.18, a +2.30% trading range. While recent weeks have seen some volatility, ONC has managed to secure a -12.76% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 324.86K shares changing hands, 225.38K more than the previous session. This amounted to $87.75M in total market activity.
Will ONC Continue Its Upward Trend?
According to analyst ratings and projections for ONC, BeOne Medicines Ltd. shares are anticipated to increase by +0.91%, potentially reaching $272.57 per share by June 19, 2026. Short-term technical indicators currently suggest a neutral sentiment for ONC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the ONC stock forecast, now is a good time to buy ONC stock because its current trading price is +3.01% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ONC covering social and institutional perspectives.
ONC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ONC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 26.21% to 35.90%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 43.07%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.91%, maintains a neutral outlook for the long term. Insights into ONC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BeOne Medicines Short-Term Forecasts
ONC Forecast For Next 5 Days
Our algorithm anticipates BeOne Medicines (ONC) stock could hit $277.18 by Jun 12, 2026. This represents a +2.62% rise from today's price, following a +0.09% change over the past five days.
ONC Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BeOne Medicines Ltd. (ONC) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $262.42, which would mean a -2.84% decrease from the current price of $270.10. Projections for this period range from a high of $288.13 to a low of $237.38.
ONC Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BeOne Medicines's price over the next three months point to a rise. ONC stock is expected to peak at $307.35 on Jul 29, 2026 before potentially dipping to $256.51 on Aug 10, 2026. On average, ONC is likely to trade around $282.00 in the coming 90 days.
BeOne Medicines Stock Forecast 2025
Based on our predictive models, BeOne Medicines (ONC) is expected to trade between $256.51 and $331.52 throughout 2026. This would result in an average price of $290.46, potentially offering investors a +7.54% return from current levels.
BeOne Medicines Ltd. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, BeOne Medicines Ltd. (ONC) is positioned to show a strong performance in June 2026. The price is predicted to move between $258.98 and $303.97, settling at an average of $281.31. This could translate to a +4.15% gain.
July 2026
Based on current market signals, BeOne Medicines Ltd. is projected to trend july 2026. We forecast a trading range from $266.91 to $307.35, with a likely average price of $286.57. Investors could expect a potential return of +6.10%.
August 2026
Our predictive algorithms indicate BeOne Medicines Ltd. stock may see a shift in August 2026. The expected range spans $256.51–$297.40, with an average target of $277.15. This represents a positive outlook and a possible gain of +2.61%.
September 2026
Analyzing established trends, BeOne Medicines Ltd. looks set to move in September 2026. Projections place the stock between $262.01 and $311.55, averaging around $287.41. This suggests a +6.41% gain from current levels.
October 2026
Market indicators suggest BeOne Medicines Ltd. could experience notable changes during October 2026. Prices could fluctuate within $262.24 to $315.26, with a midpoint forecast of $289.54. The stock might deliver a +7.20% gain.
November 2026
Forecasting for November 2026, models estimate that BeOne Medicines Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $278.80 and $331.52, averaging $302.05. This signals a positive trajectory with potential returns around +11.83%.
December 2026
According to our latest forecast models, BeOne Medicines Ltd. (ONC) is positioned to show a strong performance in December 2026. The price is predicted to move between $284.69 and $329.49, settling at an average of $306.50. This could translate to a +13.48% gain.
January 2027
Based on current market signals, BeOne Medicines Ltd. is projected to trend january 2027. We forecast a trading range from $277.71 to $321.57, with a likely average price of $298.08. Investors could expect a potential return of +10.36%.
February 2027
Our predictive algorithms indicate BeOne Medicines Ltd. stock may see a shift in February 2027. The expected range spans $285.04–$331.42, with an average target of $308.35. This represents a positive outlook and a possible gain of +14.16%.
March 2027
Analyzing established trends, BeOne Medicines Ltd. looks set to move in March 2027. Projections place the stock between $282.53 and $333.28, averaging around $309.53. This suggests a +14.60% gain from current levels.
April 2027
Market indicators suggest BeOne Medicines Ltd. could experience notable changes during April 2027. Prices could fluctuate within $297.95 to $345.37, with a midpoint forecast of $322.74. The stock might deliver a +19.49% gain.
May 2027
Forecasting for May 2027, models estimate that BeOne Medicines Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $303.52 and $350.28, averaging $327.05. This signals a positive trajectory with potential returns around +21.08%.
June 2027
According to our latest forecast models, BeOne Medicines Ltd. (ONC) is positioned to show a strong performance in June 2027. The price is predicted to move between $297.20 and $334.71, settling at an average of $316.47. This could translate to a +17.17% gain.
ONC's history of dividends and stock splits also plays a role in long-term investor confidence.

